Literature DB >> 6804126

Enzyme immunoassay for factor VIII-related antigen.

J Cejka.   

Abstract

I describe a simple enzyme-linked immunosorbent assay (ELISA) for the quantitation of Factor VIII-related antigen in plasma with use of commercially available peroxidase-labeled antiserum and solid-phase support. Regression analysis of 85 plasma samples analyzed by this technique (y) and by a commonly used electroimmunoassay (Anal. Biochem. 15: 45-52, 1966) (x) gave the equation y = 0.223 + 0.77x (r = 0.973). The present method was also compared with enzyme immunoassay in which a phosphatase-labeled antiserum prepared in our laboratory was used; the correlation between the two assays was very good. The simplicity and specificity of the ELISA technique should make it a useful alternative to the more difficult and time-consuming Laurell method.

Mesh:

Substances:

Year:  1982        PMID: 6804126

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  28 in total

1.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

2.  Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica.

Authors:  A Uddhammar; S Rantapåå-Dahlqvist; T K Nilsson
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

3.  Induction of HLA-DR antigen expression in human endometrial epithelial cells in vitro by recombinant gamma-interferon.

Authors:  S S Tabibzadeh; M A Gerber; P G Satyaswaroop
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

4.  ADAMTS13 activity is associated with early neurological improvement in acute ischemic stroke patients treated with intravenous thrombolysis.

Authors:  Anne-Sophie Putzer; Hans Worthmann; Gerrit M Grosse; Friedrich Goetz; Jens Martens-Lobenhoffer; Meike Dirks; Jan T Kielstein; Ralf Lichtinghagen; Ulrich Budde; Stefanie M Bode-Böger; Karin Weissenborn; Ramona Schuppner
Journal:  J Thromb Thrombolysis       Date:  2020-01       Impact factor: 2.300

5.  Anti-Kaposi's sarcoma and antiangiogenic activities of sulfated dextrins.

Authors:  M Thornton; L Barkley; J C Mason; S Shaunak
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

6.  Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.

Authors:  Marie Scully; Paul Knöbl; Karim Kentouche; Lawrence Rice; Jerzy Windyga; Reinhard Schneppenheim; Johanna A Kremer Hovinga; Michiko Kajiwara; Yoshihiro Fujimura; Caterina Maggiore; Jennifer Doralt; Christopher Hibbard; Leah Martell; Bruce Ewenstein
Journal:  Blood       Date:  2017-09-14       Impact factor: 22.113

7.  Factor VIII related antigen in the assessment of vasculitis.

Authors:  A D Woolf; G Wakerley; T B Wallington; D G Scott; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

8.  Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count.

Authors:  P J van Genderen; J J Michiels; S C van der Poel-van de Luytgaarde; H H van Vliet
Journal:  Ann Hematol       Date:  1994-08       Impact factor: 3.673

9.  Haemophilia A: carrier detection by DNA analysis.

Authors:  R Schwaab; J Oldenburg; M Higuchi; M Ludwig; L Kochhan; J Horst; H H Brackmann; H Egli; K Olek
Journal:  Blut       Date:  1988-08

10.  ADAMTS-13 and Von Willebrand factor in relation to platelet response during plasma exchange in thrombotic thrombocytopenic purpura: a clue for disease mechanism?

Authors:  M C Kappers-Klunne; J G van Asten; H H van Vliet
Journal:  Ann Hematol       Date:  2009-02-11       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.